Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 4
1977 3
1978 2
1979 6
1980 3
1981 2
1983 2
1984 2
1989 1
1990 1
1991 1
1992 1
1993 3
1995 1
1996 1
1997 3
1998 3
1999 1
2000 2
2001 2
2002 2
2004 4
2005 4
2006 2
2007 7
2008 7
2009 2
2010 1
2011 4
2012 3
2013 1
2015 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Alpha emitter radium-223 and survival in metastatic prostate cancer.
Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators. Parker C, et al. N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755. N Engl J Med. 2013. PMID: 23863050 Free article. Clinical Trial.
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.
Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland ØS. Nilsson S, et al. Among authors: pecking a. Eur J Cancer. 2012 Mar;48(5):678-86. doi: 10.1016/j.ejca.2011.12.023. Epub 2012 Feb 15. Eur J Cancer. 2012. PMID: 22341993 Free article. Review.
Serum chromogranin-A in advanced prostate cancer.
Ferrero-Poüs M, Hersant AM, Pecking A, Brésard-Leroy M, Pichon MF. Ferrero-Poüs M, et al. Among authors: pecking a. BJU Int. 2001 Nov;88(7):790-6. doi: 10.1046/j.1464-4096.2001.001223.x. BJU Int. 2001. PMID: 11890255
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA. Serafini AN, et al. Among authors: pecking ap. J Clin Oncol. 1998 Apr;16(4):1574-81. doi: 10.1200/JCO.1998.16.4.1574. J Clin Oncol. 1998. PMID: 9552068 Clinical Trial.
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study.
Wolff BG, Bolton J, Baum R, Chetanneau A, Pecking A, Serafini AN, Fischman AJ, Hoover HC Jr, Klein JL, Wynant GE, Subramanian R, Goroff DK, Hanna MG Jr. Wolff BG, et al. Among authors: pecking a. Dis Colon Rectum. 1998 Aug;41(8):953-62. doi: 10.1007/BF02237380. Dis Colon Rectum. 1998. PMID: 9715149 Clinical Trial.
78 results